Effect of interferon-alfa treatment in renal transplant recipients with chronic hepatitis C

Transplantation Proceedings

Volumn 30, Issue 7, 1998, Pages 3270-3272

  Tokumoto, T ^a   Tanabe, K ^a   Ishikawa, N ^a   Simizu, T ^a   Oshima, T ^a   Noguchi, S ^a   Gouya, N ^a   Nakazawa, H ^a   Hashimoto, E ^a   Fuchinoue, S ^a   Hayashi, N ^a   Toma, H ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AZATHIOPRINE; CYCLOSPORIN; HEPATITIS C ANTIBODY; METHYLPREDNISOLONE; OKT 3; VIRUS RNA;

ADULT; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFERENCE PAPER; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GRAFT SURVIVAL; HEPATITIS C; HIGH RISK PATIENT; HUMAN; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL; PROGNOSIS; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C, CHRONIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-ALPHA; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED;

EID: 13144305088     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)01024-0     Document Type: Conference Paper

References (3)

1. Marcen R, Gamez C, et al: Am J Nephrol 13:184, 1993
2. Roth D, Zucker K, Cirocco R, et al: Kidney Int 45:238, 1994
3. Kramer P, Ten Kate FWJ, Bijnen AB, et al: Lancet 8384:989, 1984